Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
BM.1.1.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
DE.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-4751.81US
BA.5.1.8NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BQ.1.19NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BF.3.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BA.5.2.4NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BA.5.1.19NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BF.7.3NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BA.2.75.4NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BA.5.1.26NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BN.6NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BF.19NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BA.5.2.51NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
AY.132 (Delta)NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.160.17NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BA.4.1.10NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
XBB.1.19NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
KF.2NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
CS.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BA.2.83NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BJ.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
XDGNSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
GA.4NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
KD.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
XCSNSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
GA.7.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
FL.15.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BA.2.40NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
CR.2NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
KB.3NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
GK.11NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
CJ.1.3.2NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
XANNSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BN.1.4.2NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
DV.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BA.5.2.11NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BA.2.53NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BA.4.3NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
EU.1.1.2NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
CM.2.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
XBB.1.43NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
HU.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
JB.2NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
AY.28 (Delta)NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-4751.81US
B.1.1.272NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.1.371NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
AA.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.1.353NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.407NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
AA.4NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used